COVID19
Clinical trials for COVID19 explained in plain language.
Never miss a new study
Get alerted when new COVID19 trials appear
Sign up with your email to follow new studies for COVID19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
COVID antibody drug trial halted: hope for severe cases unfulfilled
Disease control TerminatedThis study tested a lab-made antibody called SCTA01 in adults hospitalized with severe COVID-19. The goal was to see if it could help them recover faster. The trial was stopped early, so we don't have clear results on its effectiveness.
Matched conditions: COVID19
Phase: PHASE2, PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC
-
Stem cell therapy for COVID-19 shows promise but trial stops short
Disease control TerminatedThis phase 2 trial tested whether a single dose of umbilical cord stem cells (ProTrans®) could help hospitalized adults with severe COVID-19 avoid breathing machines or death. The study planned to enroll 60 participants but was terminated early with only 19. Both the stem cell gr…
Matched conditions: COVID19
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC
-
COVID drug trial for kids halted early
Disease control TerminatedThis study tested the drug baricitinib in children aged 1 to 18 who were hospitalized with COVID-19 and needed extra oxygen. The goal was to see if the drug was safe and how it worked in kids. Only 6 children took part before the study was stopped early.
Matched conditions: COVID19
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 18, 2026 11:49 UTC
-
Ancient herbal remedy put to the test against COVID-19
Symptom relief TerminatedThis small pilot study tested whether a traditional Chinese medicine called Xuanfei Baidu granules is safe and acceptable for people with mild to moderate COVID-19. Only 10 adults were enrolled before the study was stopped early. The main goal was to see how many people would agr…
Matched conditions: COVID19
Phase: PHASE2 • Sponsor: Darcy Spicer • Aim: Symptom relief
Last updated Jun 10, 2026 13:28 UTC
-
Web tool aims to ease tough COVID conversations
Knowledge-focused TerminatedThis study tested a web-based guide to help people have conversations about COVID-19. It enrolled 30 adults who spoke English or Spanish. The guide offered virtual conversations tailored to different concerns. The study was terminated early, so results are limited.
Matched conditions: COVID19
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 23, 2026 19:18 UTC
-
Arthritis meds and COVID: do they weaken your immune defense?
Knowledge-focused TerminatedThis study looked at whether immunosuppressive medications used for rheumatoid arthritis or spondyloarthritis change how the body fights a COVID-19 infection. Researchers compared 150 patients on these drugs with infected family members not on the same treatments. The goal was to…
Matched conditions: COVID19
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:07 UTC
-
New brain scanner peers into COVID's neurological mysteries
Knowledge-focused TerminatedThis pilot study tested a new brain PET-MR scanner to see if it can capture clear images of brain metabolism and blood flow in people who had COVID-19 and those who did not. Only 3 participants were enrolled before the study ended early. The goal was to develop an imaging protoco…
Matched conditions: COVID19
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:04 UTC
-
Smart vest monitors COVID patients
Knowledge-focused TerminatedThis study tested a special vest that tracks health data like heart rate and breathing in people hospitalized with COVID-19. The goal was to see if the vest could help doctors spot worsening symptoms early. Only 15 adults took part before the study ended early.
Matched conditions: COVID19
Sponsor: Nanowear Inc. • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:09 UTC
-
COVID-19's hidden toll on the eye revealed
Knowledge-focused TerminatedThis study looked at whether COVID-19 can damage the retina, the light-sensitive part of the eye. Researchers used special cameras to take detailed pictures of the eyes of 23 people who had COVID-19. They compared those with severe illness to those with mild cases to see if the v…
Matched conditions: COVID19
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:07 UTC